Mantle David, Hargreaves Iain P
Pharma Nord (UK) Ltd., Morpeth NE61 2DB, UK.
School of Pharmacy and Biomolecular Sciences, Liverpool John Moores University, Liverpool L3 3AF, UK.
Int J Mol Sci. 2024 Apr 22;25(8):4576. doi: 10.3390/ijms25084576.
Some 90 autoimmune disorders have been described in medical literature, affecting most of the tissues within the body. Autoimmune disorders may be difficult to treat, and there is a need to develop novel therapeutic strategies for these disorders. Autoimmune disorders are characterised by mitochondrial dysfunction, oxidative stress, and inflammation; there is therefore a rationale for a role for coenzyme Q10 in the management of these disorders, on the basis of its key role in normal mitochondrial function, as an antioxidant, and as an anti-inflammatory agent. In this article, we have therefore reviewed the potential role of CoQ10, in terms of both deficiency and/or supplementation, in a range of autoimmune disorders.
医学文献中已描述了约90种自身免疫性疾病,这些疾病会影响体内的大部分组织。自身免疫性疾病可能难以治疗,因此有必要为这些疾病开发新的治疗策略。自身免疫性疾病的特征是线粒体功能障碍、氧化应激和炎症;因此,基于辅酶Q10在正常线粒体功能中作为抗氧化剂和抗炎剂的关键作用,其在这些疾病的治疗中具有一定作用是有理论依据的。因此,在本文中,我们综述了辅酶Q10在一系列自身免疫性疾病中缺乏和/或补充方面的潜在作用。